Stem cells to treat immune problems in sepsis
Treatments studied
Part of Infections clinical trials.
This study looks at how special cells from bone marrow (called stem cells) might help fix immune problems caused by sepsis. The goal is to see if these cells can improve how your immune system works during a severe infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have been diagnosed with sepsis, a severe infection that affects your whole body
- You must have either a severe lung injury (ARDS) or septic shock (dangerously low blood pressure)
- Your blood sample must be collected within 72 hours of being admitted to the intensive care unit
- You must be able to give informed consent (or have someone who can do it for you)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how sepsis (a severe infection) affects the immune system. The goal is to see if certain blood markers can help doctors predict recovery, which could improve the care of future patients with septic shock.
This trial tests a treatment made from human umbilical cord cells to help the body fight severe infections (sepsis). It might reduce inflammation and improve recovery.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This study looks at abnormal immune cells (from the bone marrow) in people with sepsis or severe trauma with shock. It aims to understand why the body’s immune response gets out of balance, which could help guide future treatments.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.